Skip to content
zameds

Atomexetine (Xethera)

Atomexetine

Viatris South Africa (Pty) Ltd

Registration

Applicant
Viatris South Africa (Pty) Ltd
Registrations
6

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Xethera 10 MG

EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg

10 mg51098851/1.2/0988RegisteredNot determinedNone
Xethera 18 MG

EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg

18 mg51098951/1.2/0989RegisteredNot determinedNone
Xethera 25 MG

EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg

25 mg51099051/1.2/0990RegisteredNot determinedNone
Xethera 40 MG

EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg

40 mg51099151/1.2/0991RegisteredNot determinedNone
Xethera 60 MG

EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg

60 mg51099251/1.2/0992RegisteredNot determinedNone
Xethera 80 MG

EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 80,0 mg

80 mg51099351/1.2/0993RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

No structure available

This product's active ingredient could not be matched to a single known compound.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles